Irish Prostate Cancer Outcomes Research (IPCOR) registry: cohort profile

PurposeTo describe the Irish Prostate Cancer Outcomes Research (IPCOR) registry. The cohort was collected to inform and improve the prostate cancer journey of men in Ireland.ParticipantsEstablished in 2015, IPCOR was a unique large-scale prospective cohort study registering men with prostate cancer...

Full description

Saved in:
Bibliographic Details
Published in:BMJ open 2024-12, Vol.14 (12), p.e090207
Main Authors: Gordon, Noa, Dooley, Cara, Murphy, Áine, Farooq, Wasfa, Sullivan, Frank, McDermott, Ray, Sharp, Linda, Watson, William, Galvin, David
Format: Article
Language:English
Subjects:
Aged
Cancer therapies
Clinical outcomes
Cohort Profile
Hospitals
Humans
Ireland
Ireland - epidemiology
Male
Middle Aged
Oncology
Outcome Assessment, Health Care
Patient Reported Outcome Measures
Patients
Population
Prospective Studies
Prostate cancer
Prostate-Specific Antigen - blood
Prostatic Neoplasms
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - therapy
Radiation
REGISTRIES
Urology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-b331t-6efa180d9c3af932f03586e7a13928a5384785f73fe9045292afe4d7ea7045b63
container_end_page
container_issue 12
container_start_page e090207
container_title BMJ open
container_volume 14
creator Gordon, Noa
Dooley, Cara
Murphy, Áine
Farooq, Wasfa
Sullivan, Frank
McDermott, Ray
Sharp, Linda
Watson, William
Galvin, David
description PurposeTo describe the Irish Prostate Cancer Outcomes Research (IPCOR) registry. The cohort was collected to inform and improve the prostate cancer journey of men in Ireland.ParticipantsEstablished in 2015, IPCOR was a unique large-scale prospective cohort study registering men with prostate cancer in Ireland. From 2016 to 2020, IPCOR collected data on 6816 men who were newly diagnosed with prostate cancer across 16 hospitals, both public and private. A comprehensive clinical dataset was collected, capturing detailed information on men’s diagnosis, treatments and follow-up. In addition, a subset of 873 men completed patient-reported outcome measures.Findings to dateThe IPCOR study has revealed several key insights into prostate cancer diagnosis and treatment in Ireland. The data indicate a high rate of diagnosis through opportunistic Prostate-Specific Antigen screening, with many cases identified at an early stage.Future plansIPCOR invites collaboration from the global cancer research community to use this resource to advance prostate cancer research and improve patient outcomes worldwide. IPCOR aims to continue updating long-term survival follow-up data for this cohort. It also plans to continue its collaborative approach with patients, engaging with the Lived Experience Advisory Panel in interpreting results emerging from this dataset. Moving forward, IPCOR is planning its next phase of the project, IPCOR 2.0. This will be a prospective, longitudinal, multi-centre clinical quality registry and biorepository.
doi_str_mv 10.1136/bmjopen-2024-090207
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_513a80bcd29d4f449688e6f128e683ca</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_513a80bcd29d4f449688e6f128e683ca</doaj_id><sourcerecordid>3147671505</sourcerecordid><originalsourceid>FETCH-LOGICAL-b331t-6efa180d9c3af932f03586e7a13928a5384785f73fe9045292afe4d7ea7045b63</originalsourceid><addsrcrecordid>eNpdkl1rFDEUhgdRbKn9BYIMeFMvxub7wxuRRe1CYUup1yGTOdmdZWayJhmh_96su7UfuUhOkoeHQ_JW1XuMPmNMxWU7bsMOpoYgwhqkEUHyVXVKEGONQJy_flKfVOcpbVEZjGvOydvqhGpBCBfqtLpaxj5t6psYUrYZ6oWdHMR6NWcXRkj1LSSw0W3qi-XNYnX7qY6w7lOO919qFzYh5noXg-8HeFe98XZIcH5cz6pfP77fLa6a69XP5eLbddNSinMjwFusUKcdtV5T4hHlSoC0mGqiLKeKScW9pB506ZdoYj2wToKVZdsKelYtD94u2K3ZxX608d4E25t_ByGujY25dwMYjqlVqHUd0R3zjGmhFAiPSZkVdba4vh5cu7kdoXMw5WiHZ9LnN1O_Mevwx2AsCJMUF8PF0RDD7xlSNmOfHAyDnSDMyVDMkCYMKVbQjy_QbZjjVN5qT0khMUe8UB-etvS_l4cfK8DlASgJeDRgZPaxMMdYmH0szCEW9C_2rKeR</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3147671505</pqid></control><display><type>article</type><title>Irish Prostate Cancer Outcomes Research (IPCOR) registry: cohort profile</title><source>BMJ</source><source>Publicly Available Content Database</source><source>PubMed Central</source><source>British Medical Journal Open Access Journals</source><creator>Gordon, Noa ; Dooley, Cara ; Murphy, Áine ; Farooq, Wasfa ; Sullivan, Frank ; McDermott, Ray ; Sharp, Linda ; Watson, William ; Galvin, David</creator><creatorcontrib>Gordon, Noa ; Dooley, Cara ; Murphy, Áine ; Farooq, Wasfa ; Sullivan, Frank ; McDermott, Ray ; Sharp, Linda ; Watson, William ; Galvin, David</creatorcontrib><description>PurposeTo describe the Irish Prostate Cancer Outcomes Research (IPCOR) registry. The cohort was collected to inform and improve the prostate cancer journey of men in Ireland.ParticipantsEstablished in 2015, IPCOR was a unique large-scale prospective cohort study registering men with prostate cancer in Ireland. From 2016 to 2020, IPCOR collected data on 6816 men who were newly diagnosed with prostate cancer across 16 hospitals, both public and private. A comprehensive clinical dataset was collected, capturing detailed information on men’s diagnosis, treatments and follow-up. In addition, a subset of 873 men completed patient-reported outcome measures.Findings to dateThe IPCOR study has revealed several key insights into prostate cancer diagnosis and treatment in Ireland. The data indicate a high rate of diagnosis through opportunistic Prostate-Specific Antigen screening, with many cases identified at an early stage.Future plansIPCOR invites collaboration from the global cancer research community to use this resource to advance prostate cancer research and improve patient outcomes worldwide. IPCOR aims to continue updating long-term survival follow-up data for this cohort. It also plans to continue its collaborative approach with patients, engaging with the Lived Experience Advisory Panel in interpreting results emerging from this dataset. Moving forward, IPCOR is planning its next phase of the project, IPCOR 2.0. This will be a prospective, longitudinal, multi-centre clinical quality registry and biorepository.</description><identifier>ISSN: 2044-6055</identifier><identifier>EISSN: 2044-6055</identifier><identifier>DOI: 10.1136/bmjopen-2024-090207</identifier><identifier>PMID: 39622568</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Aged ; Cancer therapies ; Clinical outcomes ; Cohort Profile ; Hospitals ; Humans ; Ireland ; Ireland - epidemiology ; Male ; Middle Aged ; Oncology ; Outcome Assessment, Health Care ; Patient Reported Outcome Measures ; Patients ; Population ; Prospective Studies ; Prostate cancer ; Prostate-Specific Antigen - blood ; Prostatic Neoplasms ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - therapy ; Radiation ; REGISTRIES ; Urology</subject><ispartof>BMJ open, 2024-12, Vol.14 (12), p.e090207</ispartof><rights>Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-b331t-6efa180d9c3af932f03586e7a13928a5384785f73fe9045292afe4d7ea7045b63</cites><orcidid>0000-0001-9515-1722 ; 0000-0001-8187-6634 ; 0000-0001-6221-6067</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3147671505/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3147671505?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,55341,55350,75126,77596,77597,77660,77686</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39622568$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gordon, Noa</creatorcontrib><creatorcontrib>Dooley, Cara</creatorcontrib><creatorcontrib>Murphy, Áine</creatorcontrib><creatorcontrib>Farooq, Wasfa</creatorcontrib><creatorcontrib>Sullivan, Frank</creatorcontrib><creatorcontrib>McDermott, Ray</creatorcontrib><creatorcontrib>Sharp, Linda</creatorcontrib><creatorcontrib>Watson, William</creatorcontrib><creatorcontrib>Galvin, David</creatorcontrib><title>Irish Prostate Cancer Outcomes Research (IPCOR) registry: cohort profile</title><title>BMJ open</title><addtitle>BMJ Open</addtitle><addtitle>BMJ Open</addtitle><description>PurposeTo describe the Irish Prostate Cancer Outcomes Research (IPCOR) registry. The cohort was collected to inform and improve the prostate cancer journey of men in Ireland.ParticipantsEstablished in 2015, IPCOR was a unique large-scale prospective cohort study registering men with prostate cancer in Ireland. From 2016 to 2020, IPCOR collected data on 6816 men who were newly diagnosed with prostate cancer across 16 hospitals, both public and private. A comprehensive clinical dataset was collected, capturing detailed information on men’s diagnosis, treatments and follow-up. In addition, a subset of 873 men completed patient-reported outcome measures.Findings to dateThe IPCOR study has revealed several key insights into prostate cancer diagnosis and treatment in Ireland. The data indicate a high rate of diagnosis through opportunistic Prostate-Specific Antigen screening, with many cases identified at an early stage.Future plansIPCOR invites collaboration from the global cancer research community to use this resource to advance prostate cancer research and improve patient outcomes worldwide. IPCOR aims to continue updating long-term survival follow-up data for this cohort. It also plans to continue its collaborative approach with patients, engaging with the Lived Experience Advisory Panel in interpreting results emerging from this dataset. Moving forward, IPCOR is planning its next phase of the project, IPCOR 2.0. This will be a prospective, longitudinal, multi-centre clinical quality registry and biorepository.</description><subject>Aged</subject><subject>Cancer therapies</subject><subject>Clinical outcomes</subject><subject>Cohort Profile</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Ireland</subject><subject>Ireland - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Oncology</subject><subject>Outcome Assessment, Health Care</subject><subject>Patient Reported Outcome Measures</subject><subject>Patients</subject><subject>Population</subject><subject>Prospective Studies</subject><subject>Prostate cancer</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatic Neoplasms</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - therapy</subject><subject>Radiation</subject><subject>REGISTRIES</subject><subject>Urology</subject><issn>2044-6055</issn><issn>2044-6055</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>9YT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkl1rFDEUhgdRbKn9BYIMeFMvxub7wxuRRe1CYUup1yGTOdmdZWayJhmh_96su7UfuUhOkoeHQ_JW1XuMPmNMxWU7bsMOpoYgwhqkEUHyVXVKEGONQJy_flKfVOcpbVEZjGvOydvqhGpBCBfqtLpaxj5t6psYUrYZ6oWdHMR6NWcXRkj1LSSw0W3qi-XNYnX7qY6w7lOO919qFzYh5noXg-8HeFe98XZIcH5cz6pfP77fLa6a69XP5eLbddNSinMjwFusUKcdtV5T4hHlSoC0mGqiLKeKScW9pB506ZdoYj2wToKVZdsKelYtD94u2K3ZxX608d4E25t_ByGujY25dwMYjqlVqHUd0R3zjGmhFAiPSZkVdba4vh5cu7kdoXMw5WiHZ9LnN1O_Mevwx2AsCJMUF8PF0RDD7xlSNmOfHAyDnSDMyVDMkCYMKVbQjy_QbZjjVN5qT0khMUe8UB-etvS_l4cfK8DlASgJeDRgZPaxMMdYmH0szCEW9C_2rKeR</recordid><startdate>20241202</startdate><enddate>20241202</enddate><creator>Gordon, Noa</creator><creator>Dooley, Cara</creator><creator>Murphy, Áine</creator><creator>Farooq, Wasfa</creator><creator>Sullivan, Frank</creator><creator>McDermott, Ray</creator><creator>Sharp, Linda</creator><creator>Watson, William</creator><creator>Galvin, David</creator><general>British Medical Journal Publishing Group</general><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>9YT</scope><scope>ACMMV</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9515-1722</orcidid><orcidid>https://orcid.org/0000-0001-8187-6634</orcidid><orcidid>https://orcid.org/0000-0001-6221-6067</orcidid></search><sort><creationdate>20241202</creationdate><title>Irish Prostate Cancer Outcomes Research (IPCOR) registry: cohort profile</title><author>Gordon, Noa ; Dooley, Cara ; Murphy, Áine ; Farooq, Wasfa ; Sullivan, Frank ; McDermott, Ray ; Sharp, Linda ; Watson, William ; Galvin, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b331t-6efa180d9c3af932f03586e7a13928a5384785f73fe9045292afe4d7ea7045b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Cancer therapies</topic><topic>Clinical outcomes</topic><topic>Cohort Profile</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Ireland</topic><topic>Ireland - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Oncology</topic><topic>Outcome Assessment, Health Care</topic><topic>Patient Reported Outcome Measures</topic><topic>Patients</topic><topic>Population</topic><topic>Prospective Studies</topic><topic>Prostate cancer</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatic Neoplasms</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - therapy</topic><topic>Radiation</topic><topic>REGISTRIES</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gordon, Noa</creatorcontrib><creatorcontrib>Dooley, Cara</creatorcontrib><creatorcontrib>Murphy, Áine</creatorcontrib><creatorcontrib>Farooq, Wasfa</creatorcontrib><creatorcontrib>Sullivan, Frank</creatorcontrib><creatorcontrib>McDermott, Ray</creatorcontrib><creatorcontrib>Sharp, Linda</creatorcontrib><creatorcontrib>Watson, William</creatorcontrib><creatorcontrib>Galvin, David</creatorcontrib><collection>British Medical Journal Open Access Journals</collection><collection>BMJ Journals:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMJ open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gordon, Noa</au><au>Dooley, Cara</au><au>Murphy, Áine</au><au>Farooq, Wasfa</au><au>Sullivan, Frank</au><au>McDermott, Ray</au><au>Sharp, Linda</au><au>Watson, William</au><au>Galvin, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Irish Prostate Cancer Outcomes Research (IPCOR) registry: cohort profile</atitle><jtitle>BMJ open</jtitle><stitle>BMJ Open</stitle><addtitle>BMJ Open</addtitle><date>2024-12-02</date><risdate>2024</risdate><volume>14</volume><issue>12</issue><spage>e090207</spage><pages>e090207-</pages><issn>2044-6055</issn><eissn>2044-6055</eissn><abstract>PurposeTo describe the Irish Prostate Cancer Outcomes Research (IPCOR) registry. The cohort was collected to inform and improve the prostate cancer journey of men in Ireland.ParticipantsEstablished in 2015, IPCOR was a unique large-scale prospective cohort study registering men with prostate cancer in Ireland. From 2016 to 2020, IPCOR collected data on 6816 men who were newly diagnosed with prostate cancer across 16 hospitals, both public and private. A comprehensive clinical dataset was collected, capturing detailed information on men’s diagnosis, treatments and follow-up. In addition, a subset of 873 men completed patient-reported outcome measures.Findings to dateThe IPCOR study has revealed several key insights into prostate cancer diagnosis and treatment in Ireland. The data indicate a high rate of diagnosis through opportunistic Prostate-Specific Antigen screening, with many cases identified at an early stage.Future plansIPCOR invites collaboration from the global cancer research community to use this resource to advance prostate cancer research and improve patient outcomes worldwide. IPCOR aims to continue updating long-term survival follow-up data for this cohort. It also plans to continue its collaborative approach with patients, engaging with the Lived Experience Advisory Panel in interpreting results emerging from this dataset. Moving forward, IPCOR is planning its next phase of the project, IPCOR 2.0. This will be a prospective, longitudinal, multi-centre clinical quality registry and biorepository.</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>39622568</pmid><doi>10.1136/bmjopen-2024-090207</doi><orcidid>https://orcid.org/0000-0001-9515-1722</orcidid><orcidid>https://orcid.org/0000-0001-8187-6634</orcidid><orcidid>https://orcid.org/0000-0001-6221-6067</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2044-6055
ispartof BMJ open, 2024-12, Vol.14 (12), p.e090207
issn 2044-6055
2044-6055
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_513a80bcd29d4f449688e6f128e683ca
source BMJ; Publicly Available Content Database; PubMed Central; British Medical Journal Open Access Journals
subjects Aged
Cancer therapies
Clinical outcomes
Cohort Profile
Hospitals
Humans
Ireland
Ireland - epidemiology
Male
Middle Aged
Oncology
Outcome Assessment, Health Care
Patient Reported Outcome Measures
Patients
Population
Prospective Studies
Prostate cancer
Prostate-Specific Antigen - blood
Prostatic Neoplasms
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - therapy
Radiation
REGISTRIES
Urology
title Irish Prostate Cancer Outcomes Research (IPCOR) registry: cohort profile
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T20%3A54%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Irish%20Prostate%20Cancer%20Outcomes%20Research%20(IPCOR)%20registry:%20cohort%20profile&rft.jtitle=BMJ%20open&rft.au=Gordon,%20Noa&rft.date=2024-12-02&rft.volume=14&rft.issue=12&rft.spage=e090207&rft.pages=e090207-&rft.issn=2044-6055&rft.eissn=2044-6055&rft_id=info:doi/10.1136/bmjopen-2024-090207&rft_dat=%3Cproquest_doaj_%3E3147671505%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b331t-6efa180d9c3af932f03586e7a13928a5384785f73fe9045292afe4d7ea7045b63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3147671505&rft_id=info:pmid/39622568&rfr_iscdi=true